Technical Analysis for AGL - Angle Plc
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Flat |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Multiple of Ten Bearish | Other | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Multiple of Ten Bearish | Other | 0.00% | |
Outside Day | Range Expansion | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
NR7 | Range Contraction | 0.85% | |
Narrow Range Bar | Range Contraction | 0.85% | |
Wide Bands | Range Expansion | 0.85% | |
Multiple of Ten Bearish | Other | 0.85% | |
Wide Bands | Range Expansion | 0.85% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
Alert | Time |
---|---|
Rose Above Previous Day's High | 1 day ago |
Up 5% | 1 day ago |
Up 3% | 1 day ago |
Rose Above 10 DMA | 1 day ago |
Up 2% | 1 day ago |
Get a Trading Sidekick!
Angle Plc Description
ANGLE plc is a holding company. The Company's principal activity is undertaken in relation to the commercialization of its Parsortix cell separation system, with deployment in non-invasive cancer diagnostics. The Company is a specialist medical diagnostic company, which offers products for cancer diagnostics and fetal health. Its Parsortix cell separation system uses a microfluidic technology in the form of a one-time use cassette to capture and then harvest circulating tumor cells (CTCs) from blood. The cassette captures CTCs based on their less deformable nature and larger size compared to other blood components. The resulting liquid biopsy (blood test) enables the detection and investigation of mutations in the patient's cancer for personalized cancer care. The harvested CTCs have a range of applications, including diagnosis, prognosis, mutational analysis and drug selection, drug development, assessment of treatment effectiveness and remission monitoring.
Classification
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Health Medicine Monitoring Cancer Medical Specialties Nature Oncology Fluid Clinical Medicine Offers Products Blood Drug Development Tumor Medical Diagnostic Circulating Tumor Cell
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 163.75 |
52 Week Low | 22.2 |
Average Volume | 2,224,394 |
200-Day Moving Average | 73.13 |
50-Day Moving Average | 43.54 |
20-Day Moving Average | 31.93 |
10-Day Moving Average | 29.62 |
Average True Range | 3.52 |
RSI | 37.50 |
ADX | 22.43 |
+DI | 21.12 |
-DI | 27.40 |
Chandelier Exit (Long, 3 ATRs) | 44.45 |
Chandelier Exit (Short, 3 ATRs) | 32.75 |
Upper Bollinger Bands | 46.72 |
Lower Bollinger Band | 17.14 |
Percent B (%b) | 0.42 |
BandWidth | 92.64 |
MACD Line | -4.30 |
MACD Signal Line | -4.91 |
MACD Histogram | 0.6089 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 33.43 | ||||
Resistance 3 (R3) | 33.77 | 32.79 | 32.78 | ||
Resistance 2 (R2) | 32.79 | 31.79 | 32.63 | 32.56 | |
Resistance 1 (R1) | 31.15 | 31.17 | 30.81 | 30.81 | 32.34 |
Pivot Point | 30.17 | 30.17 | 30.01 | 30.01 | 30.17 |
Support 1 (S1) | 28.53 | 29.17 | 28.19 | 28.19 | 26.66 |
Support 2 (S2) | 27.55 | 28.55 | 27.39 | 26.44 | |
Support 3 (S3) | 25.91 | 27.55 | 26.23 | ||
Support 4 (S4) | 25.57 |